CryoPort Inc (CYRX)

[hyperopia]

Hey mike, I’ll agree that it was a good quarter. Anything stand out to you?

It was especially good news for Yescarta and Kymriah, (and therefore Cryoport) that CMS (Medicare) agreed to cover CAR-T therapies. The market seemed to like it too.

Cryoport a core holding? In my opinion, CYRX should NOT be the main part of a portfolio, and should only be a small portion of a prudent investor’s diversified portfolio. It has been pretty volatile these past couple of years. I haven’t updated my model lately but it’s showing around $35M in revenues this year and I think around $50M next year, and yet CYRX sports over a 800M market cap. So yes, revenues are growing nicely, but the valuation is becoming a bit stretched to put it mildly. (Hate to agree with CN, but I have to ; ) ) But I know you’ve been in it for a long time, and obviously have a high risk tolerance and a very long time horizon, so I think you’ll be alright.